10 August 2015
Two endoscopic bariatric therapies (EBTs) have been found to be effective in the treatment of obesity, and approved by the US Food and Drug Administration (FDA).
Scientists from the American Society for Gastrointestinal Endoscopy (ASGE) found that these new treatments could be effective as part of a broader treatment plan for patients who are seriously overweight.
The two techniques involve inserting a gastric balloon via endoscope. The patient is mildly sedated during the procedure, which is less invasive than many traditional weight-loss treatments. The saline-filled balloons help people feel fuller even though they are eating less, and are normally removed after six months. A further year of lifestyle monitoring helps the patient to maintain their weight loss.
Christopher Thompson, the chair of the ASGE’s EBT task force, said: "Endoscopic bariatric therapies offer a viable, safe alternative for patients who have been unsuccessful at weight loss with diet and exercise. They may also be appropriate for patients who are not suitable for, or are unwilling to undergo, a more invasive surgical procedure."
When the new EBTs were used as the primary method of treatment for obese patients, they lost an average of 25 per cent of their body weight over 12 months.
Posted by Edward Bartel
Health News is provided by Adfero in collaboration with Spire Healthcare. Please note that all copy above is ©Adfero Ltd. and does not reflect views or opinions of Spire Healthcare unless explicitly stated. Additional comments on the page from individual Spire consultants do not necessarily reflect the views or opinions of other consultants or Spire Healthcare.